Citations

Clear

26 citation(s) found for "Lin, Chi".

Enhancing Glycemic Control via Detection of Insulin Using Electrochemical Impedance Spectroscopy
Probst, David , Lin, Chi, Khanwalker, Mukund, Beck, Connor, Belle, Jeffrey T. La , Cook, Curtiss B. , La Belle, Jeffrey T, Malkoc, Aldin

Mayo Clinic

Journal of Diabetes Science and Technology | March 16, 2017 | Volume: 11 | Issue: 5 | Pages: 930-935

10.1177/1932296817699639 | PMID 28299957 Get It

Background: Currently, glycemic management for individuals with diabetes mellitus involves monitoring glucose only, which is insufficient as glucose metabolism involves other biomarkers such as insulin. Monitoring additional biomarkers alongside glucose has been proposed to improve glycemic control. In this work, the development of a rapid and label-free insulin biosensor with high sensitivity and accuracy is presented. The insulin sensor prototype also serves as a prior study for a multimarker sensing platform technology that can further improve glycemic control in the future. Methods: Electrochemical impedance spectroscopy was used to identify an optimal frequency specific to insulin detection on a gold disk electrode with insulin antibody immobilized, which was accomplished by conjugating the primary amines of insulin antibody to the carboxylic bond of the self-assembling monolayer on the gold surface. After blocking with ethanolamine, the insulin physiological concentration gradient was tested. The imaginary impedance was correlated to insulin concentration and the results were compared with standard equivalent circuit analysis and correlation of charge transfer resistance to target concentration. Results: The optimal frequency of insulin is 810.5 Hz, which is characterized by having the highest sensitivity and sufficient specificity. The lower limit of detection was 2.26 ρ M which is comparable to a standard and better than traditional approaches. Conclusion: An insulin biosensor prototype capable of detecting insulin in physiological range without complex data normalization was developed. This prototype will be the ground works of a multimarker platform sensor technology for future all-in-one glycemic management sensors.
Long-term quality of life (QoL) for stage II/III rectal cancer survivors in the Cancer Care Outcomes Research and Surveillance Consortium (CanCORS).
Stitzenberg, Karyn B., Juarez, Grelda Yazmin, Hálfdánarson, Þorvarður R. , Pendergast, Jane , Chrischilles, Elizabeth A. , Wallace, Robert B. , Charlton, Mary E. , Lin, Chi H. , Halfdanarson, Thorvardur R , Chrischilles, Elizabeth A

Mayo Clinic

Journal of Clinical Oncology | February 24, 2017 | Volume: 32 | Issue: 3_suppl | Pages: 584-584

10.1200/jco.2014.32.3_suppl.584 Get It

584 Background: Standard therapy for stage II/III rectal cancer includes surgery, radiation, and chemotherapy. Multiple trials demonstrated neoadjuvant chemoradiation (CRT) provides better local control and decreased morbidity compared to adjuvant CRT, though differences in overall survival and long-term QoL have not been demonstrated. We examined impact of treatment (pre-op CRT/post-op CRT/no CRT) on long-term QoL. Methods: CanCORS patients with survey/medical record data diagnosed in 2003-2005 with stage II/III rectal (non-rectosigmoid) cancer had resection and survived > 7 years were included. QoL (SF-36, EQ-5D) measures and defecation problems were derived from surveys at 14 months and 7 years post-diagnosis. Mean scores were adjusted for the following when significant: age, gender, stage, sphincter preservation, comorbidities, and baseline self-reported health status and QoL scores. Results: Of 119 patients, 53% received pre-op CRT, 23% post-op CRT, and 24% no CRT. Of 114 patients with 14-month follow-up, Pre-op CRT and No CRT groups had better EQ-5D adjusted mean scores but worse defecation scale (DS) scores compared to the Post-op CRT group. Of 49 disease-free survivors with 7 years follow-up, there were no differences among groups in QoL scores, but the No CRT group had better DS scores than other groups. Conclusions: No major differences were detected in long-term QoL based on treatment aside from the DS, though sample sizes became small. Regardless of treatment, long term (7y) mental health and vitality were generally comparable to U.S. norms, while physical health and overall health status (EQ-5D) were somewhat lower. [Table: see text]
Self-monitoring of tear glucose: the development of a tear based glucose sensor as an alternative to self-monitoring of blood glucose
Belle, Jeffrey T. La , Adams, Anngela C. , Lin, Chi-En, Engelschall, Erica, Pratt, Breanna, Cook, Curtiss B.

Mayo Clinic

Chemical Communications | June 17, 2016 | Volume: 52 | Issue: 59 | Pages: 9197-9204

10.1039/c6cc03609k | PMID 27327531 Get It

Tear glucose sensing for diabetes management has long been sought as an alternative to more invasive self-monitoring of blood glucose (SMBG).
Predictors of Long-Term Quality of Life for Survivors of Stage II/III Rectal Cancer in the Cancer Care Outcomes Research and Surveillance Consortium
Stitzenberg, Karyn B., Schlichting, Jennifer A. , Hálfdánarson, Þorvarður R. , Juarez, Grelda Yazmin, Pendergast, Jane , Chrischilles, Elizabeth A. , Wallace, Robert B. , Charlton, Mary E, Pendergast, Jane F, Charlton, Mary E. , Lin, Chi H. , Halfdanarson, Thorvardur R , Chrischilles, Elizabeth A

Mayo Clinic

Journal of Oncology Practice | July 17, 2015 | Volume: 11 | Issue: 4 | Pages: e476-e486

10.1200/jop.2015.004564 | PMID 26080831 Get It

Neoadjuvant treatment may result in better quality of life and functional status 1 year after diagnosis.
P2‐221: Daytime hypersomnolence on the multiple sleep latency test in patients with dementia with Lewy bodies
Silber, Michael H. , Lin, Siong-Chi, Tippmann‐Peikert, Maja, Ferman, Tanis J. , Boeve, Bradley F. , Smith, Glenn E.

Mayo Clinic

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_13 | Pages: No page available

10.1016/j.jalz.2008.05.1296 Get It

P2‐219: Polysomnographic evidence of sleep fragmentation and poor sleep efficiency in dementia with Lewy bodies
Silber, Michael H. , Lin, Siong-Chi, Tippmann‐Peikert, Maja, Boeve, Bradley F. , Ferman, Tanis J. , Smith, Glenn E.

Mayo Clinic

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_13 | Pages: No page available

10.1016/j.jalz.2008.05.1294 Get It